SCHEMBL4027239

SCHEMBL4027239

O=C(OCc1ccccc1)N1CCC(c2nc(-c3cccc(C(F)(F)F)c3)c(-c3ccnc(F)c3)n2O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.43
MAPK13 O15264 3/20 0.43
MAPK9 P45984 3/20 0.43
MAPK12 P53778 3/20 0.43
MAPK11 Q15759 3/20 0.43
RAF1 P04049 1/20 0.43
F2R P25116 1/20 0.42
TRPC3 Q13507 2/20 0.41
TRPC7 Q9HCX4 2/20 0.41
FAAH O00519 1/20 0.41
TRPV4 Q9HBA0 1/20 0.40
GRIN2B Q13224 7/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CETP P11597 1/20 0.39
CYP2C19 P33261 1/20 0.38
GPR119 Q8TDV5 1/20 0.38
CYP2D6 P10635 3/20 0.38
CYP2C9 P11712 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4025102 0.92 MAPK14 (0.52) MAPK14MAPK13MAPK9MAPK12MAPK11
SCHEMBL8011517 0.92 MAPK14 (0.52) MAPK14MAPK13MAPK9MAPK12MAPK11
SCHEMBL4035352 0.90 MAPK14 (0.42) MAPK14MAPK13MAPK9MAPK12MAPK11
SCHEMBL8605126 0.86 BTK (0.46) MAPK14MAPK13MAPK9MAPK12MAPK11
SCHEMBL6173126 0.86 MAPK14 (0.41) MAPK14MAPK13MAPK9MAPK12MAPK11
SCHEMBL4024827 0.83 MAPK14 (0.53) MAPK14MAPK13MAPK9MAPK12MAPK11
SCHEMBL7469105 0.83 TRPC3 (0.44) MAPK14MAPK13MAPK12MAPK11F2R
SCHEMBL4031135 0.81 MAPK14 (0.51) MAPK14MAPK13MAPK9MAPK12MAPK11
SCHEMBL4029113 0.81 TRPV4 (0.43) MAPK14MAPK13MAPK9MAPK12MAPK11
SCHEMBL6172327 0.81 MAPK14 (0.50) MAPK14MAPK13MAPK9MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0854870-B1 SUBSTITUTED IMIDAZOLES HAVING ANTI-CANCER AND CYTOKINE INHIBITORY ACTIVITY MERCK & CO INC (US) 2009-06-10 EP claimed
EP-0854870-B1 SUBSTITUTED IMIDAZOLES HAVING ANTI-CANCER AND CYTOKINE INHIBITORY ACTIVITY MERCK & CO INC (US) 2009-06-10 EP disclosed
US-6083949-A FOR TREATING CANCER IN WHICH RAF KINASE IS IMPLICATED, AS WELL AS COMPOUNDS WHICH INHIBIT, SUPPRESS OR ANTAGONIZE THE PRODUCTION OR ACTIVITY OF CYTOKINES SUCH AS INTERLEUKINS AND TUMOR NECROSIS FACTOR MERCK & CO., INC. (US) 2000-07-04 US disclosed